157 related articles for article (PubMed ID: 16974209)
41. Self-reported sedation profile of immediate-release quetiapine fumarate compared with extended-release quetiapine fumarate during dose initiation: a randomized, double-blind, crossover study in healthy adult subjects.
Datto C; Berggren L; Patel JB; Eriksson H
Clin Ther; 2009 Mar; 31(3):492-502. PubMed ID: 19393840
[TBL] [Abstract][Full Text] [Related]
42. Acute generalized exanthematous pustulosis as a side effect of quetiapine.
Lasić D; Ivanišević R; Uglešić B; Cvitanović MZ; Glučina D; Hlevnjak I
Psychiatr Danub; 2013 Mar; 25(1):84-5. PubMed ID: 23470612
[No Abstract] [Full Text] [Related]
43. Quetiapine treatment in early psychosis: no evidence of cataracts.
Whitehorn D; Gallant J; Woodley H; Rui Q; Milliken H; Kopala L
Schizophr Res; 2004 Dec; 71(2-3):511-2. PubMed ID: 15474924
[No Abstract] [Full Text] [Related]
44. Characteristics of quetiapine misuse among clients of a community-based methadone maintenance program.
McLarnon ME; Fulton HG; MacIsaac C; Barrett SP
J Clin Psychopharmacol; 2012 Oct; 32(5):721-3. PubMed ID: 22926614
[No Abstract] [Full Text] [Related]
45. Quetiapine and neuroleptic malignant syndrome.
Solomons K
Can J Psychiatry; 2002 Oct; 47(8):791. PubMed ID: 12420666
[No Abstract] [Full Text] [Related]
46. [Administration of high dose haloperidol in a patient refractory to treatment with traditional and atypical neuroleptics].
Stip E; Bruneau MA
Encephale; 1996; 22(4):298-300. PubMed ID: 9035986
[No Abstract] [Full Text] [Related]
47. Efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia.
Lee KU; Jeon YW; Lee HK; Jun TY
Hum Psychopharmacol; 2009 Aug; 24(6):447-52. PubMed ID: 19606454
[TBL] [Abstract][Full Text] [Related]
48. Statistically significant increase in weight caused by low-dose quetiapine.
Williams SG; Alinejad NA; Williams JA; Cruess DF
Pharmacotherapy; 2010 Oct; 30(10):1011-5. PubMed ID: 20874038
[TBL] [Abstract][Full Text] [Related]
49. Weight gain in a patient with schizophrenia switched from quetiapine to amisulpride.
Chen YY; Huang MC; Wu KC
Psychiatry Clin Neurosci; 2008 Oct; 62(5):620-1. PubMed ID: 18950385
[No Abstract] [Full Text] [Related]
50. Quetiapine dosage across diagnostic categories.
Khazaal Y; Chatton A; Khan R; Zullino D
Psychiatr Q; 2009 Mar; 80(1):17-22. PubMed ID: 19142727
[TBL] [Abstract][Full Text] [Related]
51. Quetiapine may induce mania: a case report.
Biancosino B; Marmai L; Facchi A; Rossi E; Grassi L
Can J Psychiatry; 2003 Jun; 48(5):349-50. PubMed ID: 12866345
[No Abstract] [Full Text] [Related]
52. Quetiapine and falsely elevated nortriptyline level.
Schussler JM; Juenke JM; Schussler I
Am J Psychiatry; 2003 Mar; 160(3):589. PubMed ID: 12611850
[No Abstract] [Full Text] [Related]
53. Less abuse potential with XR formulation of quetiapine?
Reccoppa L
Am J Addict; 2011; 20(2):178. PubMed ID: 21314763
[No Abstract] [Full Text] [Related]
54. Activation induced by high-dose ziprasidone: a case report.
Kaushik S; Maccabee N; Kaushik S; Lindenmayer JP
J Clin Psychiatry; 2009 Sep; 70(9):1326-7. PubMed ID: 19818257
[No Abstract] [Full Text] [Related]
55. Sexual functioning associated with quetiapine switch vs. risperidone continuation in outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind pilot trial.
Byerly MJ; Nakonezny PA; Rush AJ
Psychiatry Res; 2008 May; 159(1-2):115-20. PubMed ID: 18295343
[TBL] [Abstract][Full Text] [Related]
56. Quetiapine and cataracts.
Laties AM
Am J Psychiatry; 2002 Feb; 159(2):322-3. PubMed ID: 11823292
[No Abstract] [Full Text] [Related]
57. [Efficacy and tolerability of quetiapine in hospitalised schizophrenic patients during the acute treatment phase: a PMS study].
Leweke FM; Gerth CW; Koethe D; Nolden BM; Klosterkötter J
Fortschr Neurol Psychiatr; 2007 Apr; 75(4):211-9. PubMed ID: 17230308
[TBL] [Abstract][Full Text] [Related]
58. Quetiapine-induced hepatocellular damage.
Lin CH; Liu CM; Huang WL
Psychosomatics; 2012; 53(6):601-2. PubMed ID: 23157997
[No Abstract] [Full Text] [Related]
59. Olanzapine and delirium: lesson from clinical practice.
Singh D; Forlano R
Aust N Z J Psychiatry; 2008 May; 42(5):433-4. PubMed ID: 18499932
[No Abstract] [Full Text] [Related]
60. [Determining serum concentrations of the modern antipsychotic quetiapin: clinical relevance in therapeutic drug monitoring].
Köhnlein O; Lutz R; Schmauss M; Messer T
Psychiatr Prax; 2004 Nov; 31 Suppl 1():S175-7. PubMed ID: 15570545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
